Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Bad
|
New words:
abiraterone, absent, acuminate, adjourned, advantage, advice, Ahead, AIN, alpha, anal, anogenital, anticompetitive, antiviral, Aon, Appendix, array, atherosclerotic, autoimmune, Aybintio, background, Bank, BARDA, baseline, belonging, belzutifan, Bio, Biomedical, biometric, Bioscience, bound, BRCAm, BRUN, burden, capecitabine, career, ccRCC, CECH, Centene, center, checkpoint, childcare, CHRISTINE, clear, colon, compensatory, concierge, concurrent, condyloma, conference, confident, consecutive, consent, contemporary, Council, counter, CRAIG, creatinine, culture, curative, curatively, CV, cyclosporine, dampening, Dean, debilitating, distancing, dMMR, dosage, duly, Dunboyne, easy, emotional, empowerment, England, enjoy, enzalutamide, epidemic, erected, ESCC, estrogen, ethnically, EUA, excel, excellence, exhibit, feedback, fifty, FIGO, Finland, Flavor, Fortune, foster, fostering, futility, GDPR, gemcitabine, gender, genetic, genetical, genital, Glasgow, glioblastoma, globe, GLOCER, graft, GU, Guaranty, harbor, hereto, Hewitt, hired, hiring, home, HRD, Humana, hygiene, IASLC, IAVI, IMPOWER, Indenture, inferior, INGE, injunction, Inline, inspire, interactive, interplay, intraepithelial, ipilimumab, ITT, Journal, JPN, KATHY, knowledge, Koselugo, ladiratuzumab, lag, LEAP, LESLIE, Li, licensure, Linkbase, lufenuron, MACE, Melinda, mental, MFN, microchip, Microspherix, milbemycin, Minnesota, molnupiravir, Morgan, Mother, motivate, Native, NCI, neoplasia, neurological, Nexplanon, nonfatal, nonmetastatic, nonprofit, notably, NR, NRDL, nutrition, ODAC, OECD, OIG, ointment, omitted, OncoImmune, onsite, ophthalmic, Optimmune, Organon, oropharyngeal, outpace, outreach, oxime, Padcev, PAMELA, pandemic, Pandion, papillary, Paragraph, parental, parity, Parliament, PATRICIA, PAUL, payor, Petcare, PETER, phosphate, pMMR, PN, posed, praziquantel, PRC, precision, premier, premium, PrEP, Presidentand, Presidential, proactive, processed, processing, proficient, pulse, quartile, Quebec, quickly, rank, ranking, ratified, recruiting, rectum, relebactum, representation, retention, revert, revocation, Ridgeback, RISA, ROTHMAN, Roughly, RUSSO, Salary, SAR, Schema, screening, Seagen, Seattle, SEIDMAN, Sentinel, serum, sex, shareable, sick, Silgard, simultaneously, situ, skill, spread, strict, stroke, struck, subgroup, successor, sued, supplier, systematically, Takeda, talent, talented, Taxonomy, TCA, team, temperature, temporarily, thereunto, threat, THULIN, thymic, today, topline, transgender, travel, triple, Trustee, tucatinib, Tukysa, UHC, unanimously, unchallenged, unconstitutional, undersigned, underway, unexplained, University, urgent, valuable, VelosBio, venue, Verquvo, VHL, Virbac, volunteer, volunteering, von, vulvar, WARDEN, Warranty, Week, wellbeing, WENDELL, whichever, wrongdoing, XBRL, Yervoy
Removed:
aaa, accessing, Accountant, add, adding, advancement, Alto, Alzheimer, amend, amyloid, auto, backdrop, bacteremia, bench, carboplatin, card, certiorari, cleaving, cohort, comparative, compliant, complicated, composition, Condensed, conditional, constrain, constructive, differential, discharge, discrimination, discriminatory, disparate, distinct, earliest, Ebola, eDMC, enhanced, enzyme, ERISA, eroded, escrow, expedient, expressed, expressing, extinguishment, female, hostile, Hurricane, immunity, immunization, immunology, indemnification, induce, infect, innate, insuring, intensified, intratumoral, Intron, Kelli, kill, lamivudine, legacy, loan, lone, Maria, merger, Mine, modest, Moody, noncancellable, opposed, Palo, payer, pemetrexed, Perlmutter, pledged, Poor, potent, practical, preferentially, prodromal, producer, QIDP, qualifying, read, ready, redeem, repaid, repeal, replacement, replenished, resistant, retained, retaliation, retinoic, retrospective, Rigontec, Roger, secured, Shield, significance, spanning, stop, student, suffering, suppressed, tendered, tenofovir, thereto, threatening, tradename, Unresolved, uprifosbuvir, urinary, validly, Venezuela, verubecestat, writ
Filing tables
Filing exhibits
- 10-K Annual report
- 4.10 EX-4.10 Description of Merck Common Stock
- 4.11 EX-4.11 Description of 2021 Notes, 2026 Notes, and 2034 Notes
- 4.12 EX-4.12 Description of 2024 Notes and 2036 Notes
- 10.23 EX-10.23 2021 Nqso Grant Terms Under Merck Co Inc 2019 Isp
- 10.24 EX-10.24 2021 Rsu Grant Terms Under Merck Co Inc 2019 Isp
- 21 EX-21 Subsidiary List
- 23 EX-23 Consent of Independent Registered Public Accounting Firm
- 24.1 EX-24.1 Power of Attorney
- 24.2 EX-24.2 Certification of Board Resolution
- 31.1 EX-31.1 Rule 13A-14(A)/15D-14(A) Certification of CEO
- 31.2 EX-31.2 Rule 13A-14(A)/15D-14(A) Certification of CFO
- 32.1 EX-32.1 Section 1350 Certification of CEO
- 32.2 EX-32.2 Section 1350 Certification of CFO
- Download Excel data file
- View Excel data file
Related press release
Associated MRK transcripts
MRK similar filings
Filing view
External links
Exhibit 32.2
Section 1350
Certification of Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, the undersigned officer of Merck & Co., Inc. (the “Company”), hereby certifies that the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 25, 2021 | /s/ Robert M. Davis | |||||||
Name: ROBERT M. DAVIS | ||||||||
Title: Executive Vice President, Global Services, and Chief Financial Officer |